Advanced in Vasculitis

Mitsuhiro Kawano

Kanazawa, JP 
Advanced in Vasculitis
Kanazawa, JP 
OverviewLocationsClinical Research

Overview

Mitsuhiro Kawano practices in Kanazawa, Japan. Kawano is rated as an Advanced expert by MediFind in the treatment of Vasculitis. Their top areas of expertise are IgG4-Related Disease, Interstitial Nephritis, Retroperitoneal Fibrosis, Castleman Disease, and Kidney Transplant.

Their clinical research consists of co-authoring 201 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 15 articles in the study of Vasculitis.

Locations

Kanazawa, Japan
Other Locations
Kahoku, 9200293, Japan
Kensuke Yokoyama, Japan
Takaoka, 9330874, Japan
Matsumoto, Japan
Date, Japan
Tsu, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
A Phase II, Randomized, Double-Blind, Placebo-Controlled Dose-Ranging Study To Evaluate the Safety and Efficacy of M2951 in Subjects With SLE
Enrollment Status: Terminated
Publish Date: April 12, 2021
Intervention Type: Drug
Study Phase: Phase 2

201 Total Publications

Long-term safety and efficacy of upadacitinib in Japanese patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: 5-year results from the SELECT-SUNRISE randomised controlled trial.
Long-term safety and efficacy of upadacitinib in Japanese patients with rheumatoid arthritis and inadequate response to conventional synthetic disease-modifying antirheumatic drugs: 5-year results from the SELECT-SUNRISE randomised controlled trial.
Journal: RMD open
Published: August 05, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Kawano's expertise for a condition
ConditionClose
View All 16 Advanced Conditions
View All 57 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile